Showing results 1 to 20 of 44
next >
| Issue Date | Title | Author(s) |
| 2015 | Balancing affordability and availability in a drug patent regime | Pingali, Viswanath; Chatterjee, Chirantan |
| 12-May-2019 | A blot on mother's day | Chatterjee, Chirantan |
| 2020 | COILPAY: India market analysis | Tajbije, Abhishek; Singh, Arpit |
| 2016 | Competition law in india: perspectives | Pingali, Viswanath; Chaudhuri, Manas Kumar; Malik, Payal; Tamara, Ram; Kakkar, Avaantika; Chatterjee, Chirantan; Mondal, Shamim; Sokol, D Daniel |
| 2020 | Comprehensive study on electric vehicles strategy for the Indian market | P., Gouthaman; Agrawal, Nishant P. |
| 2015 | The consumer welfare implications of governmental policies and firm strategy in markets for medicines | Pingali, Viswanath; Chatterjee, Chirantan; Kubo, Kensuke |
| 2020 | COVID-19 & science, narratives & mental wellness (WIP) | P., Vaishak |
| 2013 | Crocin or paracetamol: what should the doctor prescribe? | Chatterjee, Chirantan; Kensuke, Kubo; Pingali, Viswanath |
| 7-Nov-2022 | Cross-border environmental regulation and firm labor demand | Chakraborty, Pavel; Chakrabarti, Anindya S.; Chatterjee, Chirantan |
| 2020 | Did COVID-19 lockdown impact consumption of risky fairness creams in India? | Kumar, Abhay; Singhania, Ankita |
| 2020 | Did India’s price control policy for coronary stents create unintended consequences? | Deo, Sarang; Tyagi, Hanu; Chatterjee, Chirantan; Molakapuri, Himasagar |
| 1-Jan-2024 | Did the COVID-19 pandemic propel usage of AI in pharmaceutical innovation? New evidence from patenting data | Rathi, Sawan; Majumdar, Adrija; Chatterjee, Chirantan |
| 2020 | Fake news and misinformation | Shingi, Rashish Rajendra; Bhageria, Srishti |
| 2023 | Flattening the curve: COVID-19 & grand challenges for global health, innovation, and economy | - |
| 2019 | From courts to markets: new evidence on enforcement of pharmaceutical bans in India | Chatterjee, Chirantan; Mohapatra, D. P.; Estay, M. |
| 8-Jul-2019 | Future of sports and politics: historically, popular leaders have used sports to gain the legitimacy they desperately need | Chatterjee, Chirantan |
| 1-Dec-2022 | Generic competition and the incentives for early-stage pharmaceutical innovation | Branstetter, Lee; Chatterjee, Chirantan; Higgins, Matthew J. |
| 23-Mar-2022 | How do MNEs and domestic firms respond locally to a global demand shock? evidence from a pandemic | Chatterjee, Chirantan; Adbi, Arzi; Mishra, Anant |
| 9-Feb-2021 | How does regulation impact strategic repositioning by firms across submarkets? evidence from the Indian pharmaceutical industry | Bhaskarabhatla, Ajay; Anurag, Priyatam; Chatterjee, Chirantan; Pennings, Enrico |
| 2020 | Impact of non pharmaceutical (demand side) and pharmaceutical (supply side) intervention on spread of Covid-19 | Das, Manideepto; Metre, Sunita |
